We further analyzed TMPRSS2 mRNA expression in pan-cancers and found that TMPRSS2 mRNA expression was highest in prostate cancer with 234.4 fragments per kilobase of exon model per million mapped fragments (FPKM) (Figure 1A). The gene discussed is TMPRSS2; the disease is prostate carcinoma.